• Hello Visitor!
  • Log In or Register
  • About BIO
  • BIO International Convention
  • Blogs
  • members.bio.org
  • Media
  • Contact
BIO
  • About BIO
  • BIO International Convention
  • Blogs
  • members.bio.org
  • Media
  • Contact
  • Home
  • Advocacy
    • What is Biotechnology?
    • Federal Government Relations
    • About BIO
      • Board of Directors & Executive Committees
      • Senior Staff
    • State Government Relations
    • International Advocacy
    • Letters, Testimony & Comments
    • Alliance Development
    • Amicus Briefs
  • Areas of Work
    • Health Care
      • Biopharmaceutical Manufacturing and Distribution
      • Biosimilars
      • Drug Discovery and Development
      • Food and Drug Administration Review
      • Personalized Medicine
      • Prescription Drug User Fee Act
      • Reimbursement and Health Policy
      • Vaccines and Biodefense
    • Emerging Companies
      • Capital Formation
      • Funding
      • International Market Access
      • Technology Transfer
      • Therapeutic Discovery Project Credit
    • Intellectual Property
      • Biodiversity and Bioprospecting
      • Gene Patenting
      • Patent Law Harmonization
      • Intellectual Property and Trade
      • Technology Transfer
      • Patent Reform
    • Industrial & Environmental
      • Advanced Biofuels
      • Algae
      • Climate Change
      • Marine Biotechnology
      • Renewable Chemicals & Biobased Materials
      • Renewable Specialty Chemicals
      • Synthetic Biology
    • Food & Agriculture
      • Animal Biotechnology
      • Plant Biotechnology
      • Sustainable Agriculture
    • Public Policy
      • Regulatory Affairs
      • State & Local Issues
      • State Biotech Policy
      • Stewardship
    • Bioethics
    • International Trade
    • Small Business Early Stage Investment
  • Conferences & Events
    • BIO International Convention
    • Intellectual Property
      • BIO IP Counsels Committee Conference
    • Industrial & Environmental
      • World Congress on Industrial Biotechnology
      • Pacific Rim Summit on Industrial Biotechnology & Bioenergy
    • Business Development
      • BIO Asia International Conference
      • BIO Convention in China
    • Food & Agriculture
      • BIO Livestock Summit
    • Partnered Events
      • BioEquity Europe
      • BIO-Europe
      • BIO-Europe Spring
    • Investor Events
      • BIO CEO & Investor Conference
      • BIO Investor Forum
    • Specialized Events
      • BIO Legislative Day Fly-In
      • BioSafe Annual General Membership Meeting
    • Executive Training Programs
      • Advanced Business Development Course
      • Business Development Basics
  • Industry Intelligence & Analysis
    • Backgrounders
    • Battelle Report
    • Agricultural Product Database
    • BIOtech NOW
    • Industry Best Practices
    • Publications
  • Member Services
    • Cost Savings / Discounts
    • Membership/Join BIO
    • Business Solutions
    • Membership Dues Schedule
    • Membership Benefits
    • Online Membership Application
    • Suggestion Box
    • Member Directory
  • Resources
    • BIO Grassroots Handbook
    • Food and Drug Administration
    • Council of State Bioscience Associations
    • Government Funding and Grants
    • IP Counsels Committee
    • Health Care Reform
    • Patent and Trademark Office
    • Securities and Exchange Commission
    • The Sarbanes-Oxley (SOX) Act
Home
rlycett's picture
Robbi Lycett
Vice President, Conventions & Conference

Prior to joining the Biotechnology Industry Organization in October 2005 as vice president, conventions and conferences, Robbi Lycett was president, Lycett Consulting, Inc., with 24 years in the meetings, convention and exhibition industry and has managed and produced meetings, events, conventions, and exhibitions of all sizes for association and independent organizers. Prior to starting Lycett Consulting over 7 years ago, she was vice president, CES for the Consumer Electronics Association. During her 6 years with CES, Ms. Lycett was responsible for the management, production, leadership, and strategic planning of the International CES. The International CES is one of the largest exhibitions in the world with over 1.4 million NSF of exhibition space and over 130,000 attendees. She has also been instrumental in the management and production of association meetings, conferences and conventions and has launched many new exhibitions and events. Ms. Lycett is an active member of the International Association for Exhibition Management (IAEM), and has served on various committees including the Nominating Committee, Foundation Fundraising Committee, chair of the Education Committee and is currently chair of the CEM Commission. She has been a speaker on several topics from training modules on how to write an RFP to selling your association-owned exhibition. She has served as a board member and chair of the Major American Trade Show Organizers (MATSO) and as an industry advisor to the Computer Event Marketing Association. Ms. Lycett’s prior experience in the industry includes: • National Trade Productions, Director of Ex30s • Innovative Ex30s, General Manager • National Ex30s Company, Group Show Director • Conference Management Company, Sales Manager • Cahners Ex30 Group (now Reed Exhibition Companies)

  • Join Us:

  •  
  •  
  •  
  •  
Receive our newsletter from BIOtechNOW

Subscribe to Our Newsletter

Most Viewed Articles

  • What is Biotechnology?
  • About BIO
  • Board of Directors & Executive Committees
  • BIO Members & Web Site Links
  • Join BIO

BIO Convention

BBS

  • About BIO
  • Careers
  • Privacy Policy
  • Terms of Use
  • Advertising
  • Conferences by Date
Get the main site RSS feed
Why Join BIO?
SUPPORT
BIO Business Solutions
Find out how over 2,500 companies save money with our program.
Membership FAQs
Is my organization eligible for membership? Where can I find an application to join BIO?
State Bioscience Industry Development
INDUSTRY SPOTLIGHT
Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life
Biotechnology is all around us and is already a big part of our lives.
Frequently Asked Questions: Biotech Crops and Labeling
As the use of agricultural biotechnology increases, people need information about food production that is truthful.
What is Biotechnology?
KEY INITIATIVES
Unleashing the Promise of Biotechnology
BIO released a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation.
Bioethics
Testimony on the ethical performance of international clinical trials.
Become a Sponsor
2013 BIO International Convention
ADDITIONAL RESOURCES
Industry Calendar
Learn about industry events in your area.
Submit an Event
Add your conference or event to our Industry Calendar and increase your attendance.
The BIO Grassroots Network
TOPICS OF INTEREST
Biomass & Biofuels
BIO provided Congress with information on the impact of USDA bioenergy programs.
Food & Drug Administration
A new white papershows that the FDA can help expand the economy.